To view this email as a web page, click here.
 
FDA clears first 2-drug HIV-1 regimen
FDA cleared Dovato, the first 2-drug regimen to treat HIV-1 in adults with no antiretroviral treatment history.
Read more
 
Breast cancer drug now treats men
FDA’s expansion of the breast cancer drug palbociclib (Ibrance) to treat male patients is notable, analysts say.
Read more
 
FDA issues biosimilar naming guidance
From our sister brand, Managed Healthcare Executive: FDA issued a lengthy statement on biosimilar naming conventions—but industry groups worry it could disincentivize biosimilar development.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.